Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-COVID-19 Condition (PCC or Long COVID)”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07724834
What this trial is testing

CD19-B Cell Depletion in PAIS-ME/CFS Patients

Who this might be right for
Post-acute Infectious Syndrome (PAIS)Post-COVID 19 Condition (PCC or Long COVID)Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Charite University, Berlin, Germany 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714213
What this trial is testing

Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)

Who this might be right for
Post-acute Infectious Syndrome (PAIS)Post-COVID-19 Condition (PCC or Long COVID)
Christiana Franke 138

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation